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Peptide–peptide bindingThepeptide sequence(175–192)RFPFHRCGAGPKLTKDLE(P59)of theE2envelopeproteinofGBvirusC (GBV-C)has
been proved to decrease cellular membrane fusion and interfere with the HIV-1 infectivity in a dose-dependent
manner. Based on these previous results, the main objective of this study was to deepen in the physicochemical
aspects involved in this interaction. First, we analyzed the surface activity of P59 at the air–water interface aswell as
its interaction with zwitterionic or negatively charged lipid monolayers. Thenwe performed the same experiments
with mixtures of P59/gp41-FP. Studies on lipid monolayers helped us to understand the lipid–peptide interaction
and the inﬂuence of phospholipids on peptide penetration into lipid media. On another hand, studies with lipid
bilayers showed that P59 decreased gp41-FP binding to anionic Large Unilamellar Vesicles. Results can be attributed
to the differences in morphology of the peptides, as observed by Atomic Force Microscopy. When P59 and gp41-FP
were incubated together, annular structures of about 200 nm in diameter appeared on the mica surface, thus
indicating a peptide–peptide interaction. All these results conﬁrm the gp41-FP–P59 interaction and thus support the
hypothesis that gp41-FP is inhibited by P59., Peptide sequence (175–192):
V; gp41 FP, HIV-1 FP; PC, L-α-
ne (bovine); πsat, saturation
surface pressure; Δπ, pressure
-C, GB virus C
ent, Faculty of Pharmacy, Avda
; fax: +34934035987.
quets).
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
A large number of studies have arisen from the need to overcome
AIDS infection and transmission, and to improve therapy. Several
authors [1–5] have provided evidence of a signiﬁcant reduction in
HCV-related liver morbidity associated with GB virus C (GBV-C)
(formerly known as hepatitis G virus) viremia in HCV/HIV-coinfected
patients. GBV-C infection contributes to unpredictable clinical out-
comes in these patients. It has also been proposed that GBV-C is a good
indicator for demonstrating nosocomial parenteral transmission of
viral agents [6]. Thus, GBV-C could be used to predict hospital-
acquired infection, as this virus is common in North America and
Western Europe [7,8].
Most reported studies cover clinical or genotypic aspects of the
potential interaction between HIV and GBV-C virus [1,9–11].
However, little attention has been given to the interactions between
the viral fusion peptides of these two viral families and the cellmembrane. These interactions are crucial to our understanding of the
mechanisms by which viruses enter cells and why GBV-C coinfection
with HIV decreases AIDS virulence. A full account of these mecha-
nisms should consider the concomitance between E2 protein of GBV-C
and gp41 protein of HIV-1. In particular, we need to establish whether
E2 affects protein folding and whether it forms a non-active complex
with gp41-FP.
We previously described the interaction of peptide sequences of E1
and E2 envelope proteins of GBV-C with liposomes or lipid monolayers
[12–14]. All these initial studies agree on the occurrence of electrostatic
interactions between the peptides and the polar heads of the lipids [15].
However, to our knowledge, there is no published description of the
structural and morphological changes induced as a result of the
concomitance of gp41-FP with any GBV-C peptide sequence.
Here we performed a series of studies to determine peptide–
membrane or peptide–peptide interactions in an attempt to elucidate
the mechanism by which GBV-C prevents HIV entry into cells. For this
purpose,wechosea linearpeptide thatbelongs to the region(175–192)of
theE2GBV-Cenvelopeprotein (P59) because it has shownahigh capacity
to inhibit cell-cell fusion. P59 inhibits syncitium formation in a dose-
dependent manner (IC50: 530 μM) with a lack of toxicity at the peptide
concentrations studied [16].
In the ﬁrst set of experiments, liposomes or lipid monolayers were
used asmodelmembranes to explore themode of action of the following:
i) P59; ii) gp41-FP fusion peptide (gp41-FP) and; iii) amixture of the two
peptides after their incubation at a P59/gp41-FP molar ratio of 5:1.
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lipids chosen, also affected the balance between the electrostatic
forces at the interface and the hydrophobic forces that drive the
interaction inside the membrane. The Langmuir ﬁlm studies reported
here showed that these peptides bind strongly to membranes, their
intercalation into lipid monolayers being enhanced by the presence of
negatively charged phospholipids.
The second set of experiments was designed to analyze the
morphological changes associated with the P59–gp41-FP interaction.
For this purpose, we used Atomic Force Microscope (AFM) [17–19] to
view the peptides alone and also mixed. AFM images of gp41-FP and
P59 showed spherical structures on a mica surface, indicating
aggregation of the peptides when deposited on a ﬂat surface. In
contrast, when incubated together at a ratio of 5:1 (P59–gp41-FP,
mol/mol) annular structures of 200 nm in diameter appeared on the
mica surface. These structures were aligned in chains in which each
link could be the association of one gp41-FP peptide surrounded by
ﬁve P59 peptides. These annular structures suggest changes in the
organization of the peptides as a result of the exposure of regions to
the medium. The new organization may be due to the protection of
these regions, which provides a more stable structure in the media.
All these results conﬁrm the gp41-FP–P59 interaction and,
consequently, the hypothesis that P59 inhibits gp41-FP.2. Materials and methods
2.1. Surface activity
The experiments were carried out on a NIMA Langmuir Balance
(Coventry, UK). Several volumes of a concentrated solution of P59, gp41-
FP or P59/gp41-FP (5:1) were injected into a cylindrical Teﬂon trough
with a capacity of 35 mL ﬁlled with 10 mM Tris buffer, pH: 7.4. The
subphase was stirred continuously with a miniature Teﬂon-coated rod
spinning at 150 rpm. Surface pressure, π , wasmonitored continuously by
an electronic microbalance with an accuracy of ±0.05 mN m−1 using a
platinum plate as the pressure sensor. Changes in surface pressure over
time were recorded for a minimum of 60 min. All the experiments were
carriedout in triplicate at roomtemperature (20±1 °C). Eachexperiment
was preceded by a thorough rinse and wipe of the troughs with 70%
ethanol, several times with hot deionized water and ﬁnally with double
distilled water.2.2. Kinetics of penetration and maximum insertion pressure
To determine the capacity of lipid monolayers to host the selected
peptide sequence,westudied thepenetrationkinetics of P59, gp41-FPand
mixtures of P59/gp41-FP (5:1 molar ratio). Lipids from a concentrated
solution (1 mgmL−1 in chloroform/methanol 2:1, v/v)were spread at the
air/water interface in the same Teﬂon trough as in the above experiment,
to reach the desired initial surface pressure (πo). The spreading solvent
was left to evaporate for 10 min. A peptide concentration, slightly lower
than the equilibrium spreading pressure found in the surface activity
measurements, [20]was then injected into the subphase through a lateral
hole to prevent monolayer perturbation. Depending on both the peptide
surface activity and afﬁnity for the lipid monolayer, surface pressure
increases to a steady-state upon peptide/monolayer binding, which is
called theequilibriumadsorptionpressure (πe). Thedifferencebetweenπe
and πo at different πo, named surface pressure increase, Δπ, allows the
determinationof themaximuminsertionpressure (πmax) of amoleculeby
extrapolating the regression of the plot Δπ versus πo.
P59was injected under PC, PS or PC/PS (3:2)monolayers at several πo,
while gp41-FP, mixtures of P59/gp41-FP (5:1) and P59/gp41-FP (1:1)
were studied only on the latter (3:2).
All the experiments were performed at 20°±C.2.3. Liposomes
PC/PS (3:2) large unilamellar vesicles (LUVs)were prepared following
the protocol described by Rojo et al. [21]. Brieﬂy, LUVs were prepared by
hydration of the lipid ﬁlm with tris(hydroxymethyl)aminomethane
(TRIS) 10 mM, pH 7.4 buffer followed by 10 freeze–thaw cycles. This
preparation was extruded 10 times through two 100-nm pore-size
polycarbonateﬁlters (Nucleopore, Pleasanton,CA,USA) inahigh-pressure
extruder (Lipex, Biomembranes, Vancouver, Canada).
2.4. Binding assay
The effect of E2(175–192) on the HIV-1 fusion protein (FP) binding
to model membranes was studied by the protocol described below.
Emission ﬂuorescence spectra were recorded for peptides in TRIS
buffer 10 mM, pH 7.4, at 20 °C. Peptide–phospholipid interactions
were assessed by monitoring the changes in the ﬂuorescence spectra
when LUV-PC/PS liposomes were incubated with 2 μM peptide
concentration of [8W] gp41-FP. Moreover, the E2 peptide was
premixed with the [8W] gp41-FP in dimethylsulphoxide (DMSO) in
a 5:1 ratio prior to titration with PC/PS liposomes.
The ﬂuorescence intensity was measured as a function of the lipid:
peptide ratio. Suspensions were stirred continuously and left to
equilibrate for 1 min before recording the spectrum. Fluorescence
intensities were corrected for contribution of light scattering, by
subtraction of the appropriate vesicle blank. The last correction was
obtained from a parallel lipid titration of N-acetyl-tryptophanamide
(NATA), which does not interact with lipids.
Assuming a two-state equilibrium between water-soluble aggre-
gates and membrane-bound peptides, the apparent mole fraction
partition coefﬁcients were determined by ﬁtting the binding curves to
the equations: I= fbound Imax+(1− fbound) I0, in which I is the relative
ﬂuorescence intensity, I0 is the intensity in the absence of lipid; and
fbound=Kx L /(W+Kx L), where Kx is the mole-fraction partition
coefﬁcient, L the lipid concentration andW themolar concentration of
water (55.3 M at 25 °C). This procedure followsWimley &White [22].
2.5. Atomic force microscopy
Mica squares (0.25 cm2) were glued onto a steel disc, cleaned
carefully with water before use and cleaved to obtain a ﬂat and
uniform surface. Immediately, an aliquot of 10 μL of peptides (P59 at
25 μM, gp41-FP 5 μM in milliQ water) was deposited on the mica
surface and incubated for 60 min at room temperature.
Sample was thereafter washed with milliQ water to eliminate non-
adsorbed peptides and dried to dryness. AFM contact mode images in
water were obtained using a Nanoscope IV Multimode AFM (Veeco
Metrology Group, Santa Barbara, CA) with V-shaped Si3N4 cantilevers
(MSNL, Veeco, CA) with a nominal spring constant of 0.10 N×m−1.
Instrument was equipped with an “E” scanner (15 μm). To minimize the
applied force on the sample, set point was continuously adjusted during
imaging. Imageswere acquired at 0º scan anglewith a scan rate of 1.5 Hz.
All images were processed using the Veeco software.
3. Results
3.1. Peptide synthesis
E2(175–192) was chosen because it strongly inhibits the interac-
tion and destabilization of membranes induced by the HIV FP, as
shown by several biophysical techniques as isothermal titration
calorimetry, surface plasmon resonance or vesicle content release
assays [16,23]. It bears a net positive charge and contains 4 positively
charged amino acids, which could be important for the interaction
with negatively charged phospholipid membranes.
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Fig. 1. Surface activity of A) P59 and gp41-FP and, B) P59/gp41-FPmixture (5:1) against free
air-Tris buffered interface versus concentration. The subphase was continuously stirred.
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Surface activity experiments give information about the capacity
of a peptide to adsorb or incorporate into the air-buffered interface
through the recording of the temporal change in surface pressure, π, at
constant area, after peptide injection into the subphase. The
adsorption kinetics of P59 or gp41-FP into the air-buffered interface
was measured in the subphase at a range of peptide concentrations. A
slight gradual adsorption of the peptide was observed at low
concentration. The higher the peptide concentration in the subphase,
the faster the incorporation and the higher the surface pressure
achieved. Fig. 1A illustrates the adsorption isotherm proﬁle. The shape
of the surface activity curve approached a rectangular hyperbola, and
it was ﬁtted to Eq. (1) via nonlinear least-squares regression analysis:
π=
cπsat
K + c
; ð1Þ
where c is the concentration, π1sat the saturation pressure or
maximum pressure that can be achieved, and K is a characteristic
constant equal to the peptide concentration that reaches half πsat.
Fitting the data of P59, the values obtained were πsat=13.80±
1.8 mNm−1; K=167.0±62.6 nM (R2: 0.9576). A slightly lower value
of K, 138 nM, was chosen for further penetration studies as it
corresponds to the optimum peptide concentration that should be
used in the bulk subphase for experiments of penetration kinetics,
lower than the equilibrium spreading pressure of the peptide [20]. For
gp41-FP results were πsat=79.50±4.1 mN m− 1; K=521.0±
35.5 nM (R2: 0.9720).
On the basis of these results, it is possible to calculate the peptide
surface excess concentration by applying the Gibbs adsorption
equation in its simplest form (Eq. (2)).
Γ=
1
RT
Δπ
Δ lnc
; ð2Þ
where R is the gas constant (8.314 J K−1 mol−1), T is the temperature
(293 K),Δπ is the pressure increase achieved 30 min after injection, and c
is the peptide concentration.
The surface excess concentration was 1.28×10−6 and 4.75×10−6
mol m−2, for P59 and gp41-FP, respectively which correspond to a
molecular surface area of 1.29 nm2 for P59 and 0.35 nm 2 for gp41-FP
as calculated with Eq. (3):
A =
1
ΓN
ð3Þ
where N is Avogadro's constant.
The values are of the same order as those found for other peptide
sequences of the same family [14,15,24].
In order to ﬁnd out the effect of P59 on gp41-FP surface activity, the
same set of experiments was donewith the P59/gp41-FP (5:1mixture).
Results are reported as surface pressure versus P59 concentration
(Fig. 1B). When the equivalent concentration of gp41-FP in themixture
was injected alone, the surface pressure was higher. Therefore, when
P59 was incubated with gp41-FP and then injected, the rectangular
hyperbola approached the values registered for P59 alone, suggesting
that gp41-FP activity was neutralized (πsat=19.1±2.1 mN m−1;
K=250.0±9.5 nM; R2: 0.9836). These results indicate an inhibitory
effect of P59 on gp41-FP surface activity.1 Many authors express this concept as πmax but in the present paper we name it πsat
to avoid misunderstanding with the maximum insertion pressure, expressed as πmax
that will appear in the next section.3.3. Kinetics of penetration and maximum insertion pressure
The Langmuir ﬁlm studies revealed that P59 and gp41-FP bind
strongly to membranes, their intercalation into lipid monolayers
being enhanced by the zwitterionic/negatively PC/PS (3:2) mixture.
PC is the major component of the outer leaﬂet of uninfected cells,
whereas PS, a hallmark of programmed cell death, is expressed at
elevated levels in HIV-1-infected T cells and macrophages because of
the association of apoptosis with the progression of AIDS [25–28].
Themaximuminsertionpressure (πmax) corresponds to themaximum
surface pressure (minimum surface area) of the monolayer at which the
interaction of a peptide with the lipids is energetically favorable. It is a
useful parameter to determine the capacity ofmolecules of interest, in the
present case peptides, to penetrate cell membranes. In lipid monolayers,
πmax values of proteins are useful to characterize protein adsorption and
lipid speciﬁcity without the need to use radiolabels or other tags [29].
Large πmax values (34–36 mN m−1) have been reported for apolipopro-
teins and their C-terminal amphipathicα-helix. In contrast, low values of
πmax (17–29 mN m−1) correlate well with the lower capacity of N-
terminal α-helices of apoproteins for the same function. Therefore, given
that themembrane lateral pressure has been estimated to be between 30
and 35 mN m−1, values found below this range indicate a lack of
penetration while those above are characteristic of membrane-active
compounds [30].
We performed various P59 penetration experiments using two
phospholipids that differed in the nature of the head group: PC,
zwitterionic, and PS, negatively charged, and a mixture of PC/PS (3:2).
All the monolayers are in the liquid expanded state at the temperature
used (ca 20 °C).
When the monolayer was of pure PC, a linear plot of Δπ versus πo
was obtained. The higher the πo, the lower the Δπ regardless of
peptide concentration in the subphase. In contrast, for PS monolayers,
Δπ was highly dependent on P59 concentration. The initial experi-
ments with P59 were done by injecting this peptide into the Teﬂon
trough at a ﬁnal concentration of 276 nM. In these experiments, Δπ
was very similar to each initial surface pressure assayed, πo, except for
1570 I. Haro et al. / Biochimica et Biophysica Acta 1808 (2011) 1567–1573πo higher than 30 mN m−1 as an indication of monolayer saturation.
When the concentration of P59 in the subphase was lower than
138 nM, a linear relationship was observed. Consequently, we chose
this concentration for further experiments. These results show not
only the high electrostatic component of the P59/membrane
interaction, but also the utility of surface activity measurements to
calculate the appropriate amount of sample to be injected into the
subphase.
πmax values found for P59 were slightly higher for PS and for PC/PS
(3:2) (around 41 mNm−1) than for PC (36 mNm−1), thereby indicating
a better uptake by negatively charged phospholipids. Therefore, the PC/PS
mixture (3:2) was chosen for the following experiments.
The next step was to analyze the interaction of gp41-FP and a P59/
gp41-FP (5:1) mixture with PC/PS (3:2) monolayers. The various plots of
pressure variation versus the initial surface pressure are shown in Fig. 2.
The maximum insertion pressures on PC/PS (3:2) monolayers
obtained from extrapolation of the Δπ plot versus πo to Δπ=0 were as
follows: 41 mNm−1 for P59; 32 mNm−1 for gp41-FP and46 mNm−1 for
P59/gp41-FP (5:1). The πmax values of P59 alone or after incubation with
gp41-FP were similar, what makes difﬁcult the elucidation of the
mechanism of the interaction. However, these values were consistent
with surface activity measurements.
Given that the P59/gp41-FP molar ratio seems to be crucial for the
inhibition, the kinetics of peptide insertion into PC/PS (3:2) monolayers
was also studied at a P59/gp41-FPmolar ratio of 1:1. Leakage experiments
showed that when P59 was present at this molar ratio, it did not inhibit
gp41-FP activity. In contrast, synergism between the two peptides was
observed. Results gave a πmax of 38 mNm−1, lower than the 46 mNm−1
found for the P59/gp41-FP (5:1) molar ratio. In both experiments, the
concentration of gp41-FP injected into the subphase was the same
(28 nM) but the concentration of P59 was lowered to 28 nM. At this
concentration, P59 did not show a signiﬁcant pressure increase even at
low πo but there was an increase in the πmax of gp41-FP when incubated
with P59. If the behavior observed in penetration kinetics were a
consequence of the activity of gp41-FP and P59 in an independent way,
one would have expected a lower πmax, equal to πmax of gp41-FP when
injected alone. Therefore, the increase in pressure appears to be a
consequence of a P59–gp41-FP complex.
Although the data obtained with the Langmuir method are not
enough to draw a clear conclusion, the results support the hypothesis
of the formation and interaction of a P59–gp41-FP complex.
However, taking into consideration the charge of the peptides and
the AFM observations (see below), we can relate electrostatic
interactions of the peptides with the results on the kinetics of
penetration. On the basis of the peptide sequences, P59 has 6 positivePC/PS (3:2)
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Fig. 2. Variationof the surfacepressure as a functionof the initial surfacepressureof thePC/PS
(3:2) phospholipidmonolayer: black: gp41-FP; green: P59; red: P59–gp41-FP (5:1). P59 and
gp41-FP concentration into the subphase (Tris pH:7.4) was 138 nM and 28 nM. This same
concentration was injected when studying the mixture P59/gp41-FP (5:1).and 2 negative charges while gp41-FP has a single positive charge at
the N-terminus (Table 1). Taking into account the charge distribution
in the molecules, there may be an electrostatic attraction between the
positive charge of gp41-FP and one of the negative charges of P59.
Such an attractive force would lead to the formation of a peptide
complex P59/gp41-FP and would be responsible for the increases in
surface pressures observed. This longer structure would have two
regions, one composed of neutral amino acids acting as hydrophobic
tail, and another with positively charged amino acids, behaving as a
polar head. Therefore, the activity of the P59/gp41-FP complex in PC/
PS (3:2) monolayers would be the consequence of both electrostatic
and hydrophobic interactions, as observed for P59 alone.
It is also relevant to point out that these results were observed only
when peptides were incubated before their injection into the subphase;
however, this effect was not detected when peptides were injected in a
sequential way, ﬁrst P59 and then gp41-FP or vice versa.
3.4. Binding results
The interaction of P59 E2 peptide with HIV-1 FP or gp41-FP was
examined by measuring its partitioning into PC/PS liposomes. The
maximum wavelength of Trp emission (λmax) of HIV-1 FP or gp41-FP
shifted toward the blue in the presence of PC/PS LUVs (Fig. 3A).
Speciﬁcally, λmax decreased by more than 10 nm, which is consistent
with the movement of HIV-1 FP or gp41-FP FP into a non polar
environment of vesicle bilayers. The incubation of P59 with HIV-1 FP or
gp41-FP prior to PC/PS titration prevented the shift of the Trp emission
ﬂuorescence (Fig. 3B). This observation thus indicates an interaction of E2
P59 with HIV-1 FP or gp41-FP that prevents the movement of the Trp
residue to an environment of lower polarity provided by the vesicles.
Fluorescence titration was used to measure HIV-1 FP or gp41-FP
partitioning quantitatively by measuring ﬂuorescence intensity at the
λmax (346 nm). The partitioning isotherms (Fig. 3C) show thatHIV-1 FP or
gp41-FP partitioned strongly into PC/PS vesicles (Kx=1.9×106). The
mole-fraction partition coefﬁcient for HIV-1 FP or gp41-FP/P59 was
2.7×105, indicating that P59 impededHIV-1 FP or gp41-FP binding to the
PC/PS, the partition coefﬁcient resulting one order of magnitude lower.
The interaction of synthetic peptides derived from HIV-gp41-FP
and model membranes has been reported in several studies. Some
agree in the efﬁciency of these peptides in inducing lipid mixing of
negatively charged membranes whereas their activity toward
zwitterionic membranes is very low [31,32]. However, a study of
Kliger et al. [33] of a synthetic peptide (DP178) corresponding to a
segment of gp41 of HIV-1 with either negatively charged or
zwitterionic vesicles yielded similar results in binding experiments.
In our study, as far as the physicochemical aspect of the interaction is
concerned, results evidence the important role of both electrostatics
and hydrophobic contribution in the fusion mechanism.
3.5. AFM observations
Up to know there are few references reporting the interaction of
gp41-FP with lipid membranes by AFM [28]. Recently, Bitler et al. [34]Table 1
Peptides characterization.
Peptide Amino acid
sequencea
Net charge HPLC
(k’)b
ES-MSc
E2(175–192) RFPFHRCGAGPKLTKDLE +4 3.8 2072,42
gp41 FP AVGIGALFLGFLGAAGSTMGAAS +1 4.7 2036,80
[8W] gp41 FP AVGIGALWLGFLGAAGSTMGAAS +1 3.4 2076,40
High performance liquid chromatography (HPLC) conditions: A: H2O 0,05%
triﬂuoroacetic acid (TFA)]; B: acetonitrile (0,05% TFA). Gradient 95% A to 5% A in
30 min, 1 mL min-1. Kromasil C-18 column. Detection 215 and 280 nm.
a In italics and bold the cationic amino acid, underlined the anionic amino acid.
b Capacity factor.
c Electrospray mass spectrometry.
Fig. 3. Fluorescence emission spectra of: A) HIV-1 FP or gp41-FP and B) HIV-1 FP or gp41-FP/ P59 (1/5) mixture upon titration with PC/PS LUVs. C) Partitioning curves as estimated
from the fractional change in Trp ﬂuorescence in the presence of increasing amounts of PC/PS LUVs. The solid lines correspond to the best ﬁts of the experimental values to a
hyperbolic function. ○ HIV-1 FP or gp41-FP ; ● HIV-1 FP or gp41-FP / P59 (1/5).
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two mutants in the post-fusion state with nanometer resolution by
AFM. AFM images revealed differences in the interaction of the three
types of protein with zwitterionic and negatively charged membranes.
In the present work, AFM was used to study the structure and self-
assembly of the twopeptides and theirmixture on themica surface. Large
round aggregates of peptide gp41-FP formed all over the surface (Fig. 4A).
These aggregates showed a step height of 82±10 nm with a mean
diameter of 330±30 nm. Aggregateswere randomly distributed over the
mica surface and no individual peptideswere observed. In contrast round
P59 peptide aggregates were smaller than gp41-FP aggregates with a
height of 9.1±1.6 nmwith a mean diameter of 150±30 nm (Fig. 4B). In
this case, the mica surface was fully covered with a thin ﬁlm. Although
peptide aggregates were stable against contact mode scanning, the thin
ﬁlm was not. This effect can be observed from the enlargement of some
soft features in the direction of the scan (horizontal).
Fig. 5 shows the adsorption of amixture of P59 and gp41-FP (5:1,mol/
mol) on the mica surface. The mixed peptides adsorbed aligned in
preferential directions to form lines (Fig. 5A). Fig. 5B is a zoom image of
these lines with an angle of 130±5° from the scan direction (horizontal).
These lines can be identiﬁed as chains where each link is the pattern that
repeats. Links (Fig. 5C) are ringswith elliptical shapewithaheight of 1.3±
0.4 nm, ﬁrst diameter of 130±30 nm nm, second diameter of 98±
15 nm and with a ring thickness of 26±6 nm.
The capacity of gp41-FP to form larger aggregates on mica (polar
surface) than P59 suggests that peptides differ in their behavior when
they interact with mica. The image of gp41-FP indicates more
hydrophobic interactions than P59 (strongly charged), which can
form a thin ﬁlm on the mica surface.Annular structures suggest morphological changes in the organi-
zation of peptides when gp41-FP and P59 were mixed in solution
before deposition on the mica surface. P59 might stabilize gp41-FP
molecules in solution, thereby protecting hydrophobic regions from
the media. One possible scenario for the links could be the formation
of mixed micelles: gp41-FP hydrophobic regions could arrange to
form concentric and elongated structures. Positively charged amino
acid on gp41-FP may be on the surface of the tube where P59 could be
adsorbed (electrostatic interaction), thus stabilizing the structure
against the media (Fig. 6).
When the same experiments were done with a mixture of P59/gp41-
FP (1:1, mol/mol), these structures were not observed. These results do
not match with the obtained with Langmuir studies in which no
differences in interaction where observed at different P59/gp41-FP
molar ratios. However, the AFM studies were performed under different
experimental conditions to the monolayer experiments. While mono-
layerswere donewith samples in solution, in AFM, peptideswere ﬁxed to
a negatively charged mica surface.
4. Conclusions
Using various techniques, here we have shown the capacity of P59,
a sequence of the E2 protein of GBV-C virus, to inhibit gp41-FP.
Monolayer experiments showed a high surface activity of gp41-FP
and to a lesser extent of P59. However, when peptides were mixed,
surface activity was of the same order as that of P59, much lower than
that observed for gp41-FP alone. Furthermore, P59, gp41-FP and their
mixtures interacted with negatively charged lipid monolayers and to a
lesser extent with zwitterionic monolayers. The values of πmax obtained
Fig. 4. AFM images of adsorbed peptide on mica surface, A) gp41-FP at a concentration of
5 μΜandB)P59ataconcentrationof25 μΜ. Contactmode in liquid.Height scalebar is20 nm.
Fig. 5. A) AFM image of absorbed peptide mixture of gp41-FP and P59 (5:1, weight/weight)
on mica surface. B) Zoom image from a) where chains are formed by links, and C) High
magniﬁcation of one of these links. Contact mode in liquid. Height scale bar is 20 nm.
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afﬁnity for phospholipidmonolayers. Indeed,most of the πmaxwere over
30 mN m−1, i.e., above the estimated lateral pressure of membranes.
This observation suggests that the interactions of the peptides with
biological membranes are thermodynamically favorable. Despite the
high values of πmax for all the samples, themixture P59/gp41-FP showed
a lower value than the one observed for gp41-FP alone indicating a
change in activity of gp41-FP in thevicinity of themonolayer. In addition,
wepropose that peptide/s–lipidmonolayer interactions (at P59/gp41-FP
molar ratios of 5:1 and 1:1) are governed mainly by electrostatic
interactions but a hydrophobic contribution is also present.
Studies performed with lipid vesicles also indicated the capacity of
P59 to decrease gp41-FP contact with the lipid membrane. This
interaction was conﬁrmed by AFM images showing different
interaction of peptides with the polar surface of mica. While
individual peptides aggregated in a different manner on the mica
surface, the mixture formed a particular structure at a molar ratio of
P59:gp41-FP (5:1) but not at a molar ratio of P59:gp41-FP (1:1). It is
necessary here to clarify that peptide interactions with mica surface
are not the same as those found with lipid membranes. In addition,
the interaction of peptides with mica provides information on the
interactions of peptides alone, and especially on the capacity of the
mixture at a molar ratio of P59:gp41-FP (5:1) to modify their
structure to form more stable aggregates in solution. One working
hypothesis is that, at the nanoscale, gp41-FP molecules are
surrounded by P59 molecules, which thus prevent the fusion of
gp41-FP molecules with membranes.
Furthermore, many events at the membrane level are caused by
conformational changes of peptide sequences when they are in thevicinity of the host cell. P59 has a short chain of 18 amino acids and it
adopts an amphipathic random coil structure in aqueous solution, like
other peptides of the same family [23]. In contrast, gp41-FP adopts a
β−turn structure under the same conditions [35]. Herrera et al. [13]
have shown that E2(259–287) interacts with HIV-1 FP and modiﬁes
its conformation. Therefore further studies should be developed to
clarify the role of P59 in gp41-FP inhibition. This line of research
should cover not only the conformational aspects of the interaction
but also the stoichiometry of binding or the depth in which the
sequences interact with the host membrane.
Fig. 6. Cartoon showing the possible organization of P59 and gp41-FP mixtures (P59/
gp41-FP: 5:1, mol/mol) deduced from AFM results. Left) AFM image; Top Right) Cut of
the wire showing the proposed mixed micellar structure formed by electrostatic
attraction between the positive terminal charge of gp41-FP and one of the negative
terminal charges of P59. Bottom Right) longitudinal view of the wire organized as an
annular structure formed by P59/gp41-FP mixtures.
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